How I Treat mCRC in the Community: Think Chess, Not Checkers!

In the Clinic . . . Consider the following patient cases encountered in my clinic. Case 1: Indolent Disease, Long-Term Disease Control A 59-year-old male was […]

Redefining Second-Line Treatment Strategy, Sequencing, and Real-World Implementation in Relapsed/Refractory Multiple Myeloma: Insights From the 31st Annual Congress of the European Hematology Association

Abstract: The management of relapsed/refractory (R/R) multiple myeloma (MM) continues to evolve with the introduction of novel therapies and the use of newer therapies in different treatment […]

Case Study Series

PNH Management: A Clinical Case of Ravulizumab–Danicopan Combination Therapy

About the Patient Patient EW is a 56-year-old woman who was diagnosed with paroxysmal nocturnal hemoglobinuria (PNH) 9 years ago, at the age of 47. At […]